Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects by Sairanen, U. et al.
ORIGINAL ARTICLE
Yoghurt containing galacto-oligosaccharides, prunes
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Objective: Constipation is a common problem in the elderly. Dietary fibre is recommended for its treatment. The aim was to
examine whether yoghurt containing galacto-oligosaccharides (GOS), prunes and linseed relieve constipation in elderly
subjects.
Design: A randomized, double-blinded, cross-over study.
Setting: Free-living subjects.
Subjects: A group of 43 elderly subjects with self-reported constipation (mean age 76 years, range 61–92 years, 32 females, 11
males).
Interventions: The study consisted of a 2-week baseline period and 2, 3-week dietary interventions, with a 2-week wash-out
period between the interventions. During the interventions, the subjects ingested, in random order, 260g/day of either control
yoghurt or test yoghurt containing GOS (12g/day), prunes (12g/day) and linseed (6 g/day). The use of laxatives was controlled
and only allowed after 2 days without defecation.
Results: Defecation frequency was 5.7 times/week during the baseline period. During the test yoghurt period, defecation
frequency was higher (8.0 vs 7.1 times/week, P¼0.011), defecation was easier (on the scale 0–3, 1.3 vs 1.5, P¼0.010), and
there was a tendency towards softer stools (on the scale 0–3, 2.1 vs 2.2, P¼0.059) compared with the control yoghurt period.
The subjects felt that the test yoghurt relieved constipation more effectively than the control yoghurt (P¼0.005). The sum of
gastrointestinal symptoms did not differ between the interventions. The use of laxatives remained constant throughout the
study.
Conclusions: Daily intake of yoghurt containing GOS, prunes and linseed reduced the severity of constipation in elderly subjects
with mild constipation.
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Introduction
Constipation is a common problem among the elderly
(Schaefer and Cheskin, 1998). Elderly people often have to
use a wide range of medicines, some of which cause
constipation as a side effect. When people grow older, food
intake decreases as their energy need is reduced, and it
becomes difficult to achieve the intake of dietary fibre
usually recommended for preventing constipation (Taylor,
1990).
Galacto-oligosaccharides (GOS) act as soluble fibres as they
pass undigested into the colon, where they are hydrolyzed
and fermented by the bacteria (Delzenne, 2003). GOS are
composed of lactose and galactose units (Zarate´ and Lo´pez-
Leiva, 1990), and are found naturally in, for example, human
milk (Kunz and Rudloff, 1993; McVeagh and Miller, 1997;
Kunz et al., 2000). The prebiotic, bifidogenic effects of GOS
or a mixture of GOS and fructo-oligosaccharides on the
colonic microbiota have been shown in infants (Boehm
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et al., 2002; Moro et al., 2002; Knol et al., 2005; Rinne et al.,
2005) as well as in adults (Ito et al., 1990; Bouhnik et al.,
1997; Gopal et al., 2003), and GOS are therefore considered
beneficial to human health. As GOS are fermented in the
colon, the bacterial mass increases and this in turn increases
faecal bulk and softens stools. In a previous study, we found
that in most elderly subjects a daily dose of 9 g GOS relieved
constipation (Teuri and Korpela, 1998). GOS have been
found to relieve constipation in Japanese studies, too
(Deguchi et al., 1997; Shitara, 1988). GOS are in general
well-tolerated (van Dokkum et al., 1999; Boehm et al., 2002;
Moro et al., 2002). However, because of fermentation,
symptoms such as abdominal bloating and flatulence may
occur in sensitive subjects when large quantities of GOS are
ingested (Ito et al., 1990; Teuri et al., 1998).
Prunes are known to soften stools and to relieve constipa-
tion (Muller-Lissner et al., 2005a) and have been shown to
increase faecal output in non-constipated men (Tinker et al.,
1991). Their efficacy in elderly subjects has been reported in
a few early studies in which prunes in yoghurt (Ferrer and
Boyd, 1955) or prunes with cascarin (Stern, 1966) or fibre
(Hull et al., 1980) have been ingested. The laxative action of
prunes could be explained by its relatively high fibre and
sorbitol content (Stacewicz-Sapuntzakis et al., 2001). Prunes
also contain phenolic compounds, mainly in the form of
neochlorogenic and chlorogenic acids, which may aid the
laxative action (Stacewicz-Sapuntzakis et al., 2001).
Linseed is traditionally used for relieving constipation, and
50 g per day has been found to increase bowel movement in
subjects with normal bowel function (Cunnane et al., 1995).
Linseed acts as a swelling, bulk-forming agent. Its stimulat-
ing effect on bowel movement may be partly owing to its
high fibre content, especially of the soluble fibre, known as
mucilage, which surrounds the linseed.
Serious constipation requires medical treatment, that is,
laxatives. In mild constipation, nutritional therapy is often
preferred. We therefore examined the possibility that in the
elderly, a yoghurt containing 12 g GOS, 12 g prunes and
6 g linseed per day might reduce the severity of mild, self-
reported constipation, compared with traditional yoghurt.
Materials and methods
Subjects
The study population consisted of 43 elderly subjects (460
years, mean age 76 years, range 61–92 years, 32 female, 11
male, Table 1), who were classified as suffering from mild
constipation as either (1) their bowels functioned less than
five times per week without laxatives, or (2) they complained
of difficulty in defecation. They suffered from various age-
related chronic diseases and used a wide range of medicines.
All the subjects were ambulatory and lived either on their
own or in homes for the elderly. There were no dietary
exclusion criteria.
The study protocol was accepted by the local ethics
committee. Informed, written consent was obtained from all
the subjects.
Design
The study was performed as a randomized two-period cross-
over study and lasted 10 weeks. First, there was a 2-week
baseline period, followed by the first intervention of 3 weeks,
a wash-out period of 2 weeks, and finally a second 3-week
intervention period. The subjects were randomly assigned
to one of the two groups, which determined the order of
consumption of the two yoghurts. The subjects were
randomized in blocks, and the randomization was stratified
according to defecation frequency during the first week of
the baseline period.
Both the test yoghurt and the control yoghurt were fermen-
ted with Lactobacillus acidofilus species and Bifidobacterium
lactis (Wisby, Tonder, Denmark). GOS syrup (Elixor,
Borculo Whey Products, Borculo, the Netherlands) and jam
containing linseed and prunes were added to the test yoghurt:
one test yoghurt portion contained 6g GOS, 6g prunes and
3g linseed. Artificial prune flavour and jam containing a small
quantity of prunes (0.2g per yoghurt) were added to the
control yoghurt to make its appearance and taste as similar as
possible to the test yoghurt. Even so, the appearance of the
yoghurts differed slightly, but the subjects were not told
which was supposed to be the effective one.
Two yoghurts (each 130 g) were ingested per day, one in
the morning and one in the evening, with the exception of
the first 4 days of the 3-week intervention periods, when
only one yoghurt was ingested per day to reduce the
Table 1 Baseline characteristics of the study subjects. Results are
expressed as number of subjects or as mean (range)
Subjects (n¼43)
Females/males, (n) 32/11
Age, years (range) 76 (61–92)
Weight, kg (range) 78 (56–112)
BMI, kg/m2 (range) 28.3 (21.0–41.8)
Fibre intake, g/day (range) 22.3 (8.9–43.9)
Use of laxatives
Daily or weekly, (n) 15
Less than weekly, (n) 4
Did not use, (n) 24
Period of constipation
Over 20 years, (n) 14
3–20 years, (n) 15
Less than 3 years, (n) 14
Exercise such as walking outside
Every day, (n) 32
Sometimes, (n) 7
None or minimal, (n) 4
Abbreviation: BMI, body mass index.
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gastrointestinal symptoms sometimes caused by a sudden
high fibre addition to the diet. After the first 4 days of the test
yoghurt period, the intake of GOS was 12g per day, prunes
12g per day and linseed 6g per day. At the end of the
intervention periods, the subjects were asked to return any
remaining yoghurts or else the fridge was checked, so that the
actual quantity of yoghurt consumed could be calculated.
Once the study began, the subjects suspended their
normal use of laxatives. During the whole study, including
the baseline period, laxatives were used only if there was no
defecation for 2 whole days. In this case, on the third day,
a laxative (Visiblin, Parke-Davis Scandinavia AB, Solna,
Sweden) was taken, and if defecation did not follow, a
similar laxative (Visiblin) was taken the next morning and a
different laxative (Pursennid, Sandoz Pharma AG, Basel,
Swizerland) in the evening. On the sixth day an enema
(Microlax, Pharmacia & Upjohn AB, Stockholm, Sweden)
was finally administered if defecation was not likely to be
induced with milder laxatives. All laxatives were adminis-
tered according to the instructions of the manufacturer. The
subjects continued to consume yoghurts regularly even
when they were taking laxatives.
Questionnaires
The subjects were questioned about their intake of dietary
fibre three times during the study, using a dietary fibre
frequency questionnaire for the previous week (Ja¨ka¨la¨ et al.,
1994). At the same time they were asked about their liquid
intake in the course of an ordinary day by means of a drink
questionnaire. Interviews were held at the end of the
baseline period and of both intervention periods. Before
the study, 7 weeks after the beginning of the study, and
immediately after the study, the subjects were weighed and
questioned about exercise and medication. The subjects were
asked to retain their normal diets.
Throughout the study, the subjects filled in daily a
questionnaire concerning faecal frequency, consistency of
faeces (0¼watery, 1¼ soft, 2¼normal, 3¼hard) and diffi-
culty of defecation (0¼ easy, 1¼ fairly easy, 2¼ rather
difficult, 3¼difficult), as well as about flatulence, abdominal
pain and abdominal bloating (each, 0¼no symptom,
1¼mild symptoms, 2¼moderate symptoms, 3¼ severe
symptoms). The use of laxatives was also registered.
Practically, all the subjects were visited twice a week to
make sure that the questionnaires were filled in correctly.
Immediately after the intervention periods, the subjects
evaluated the effects of the yoghurt on their constipation
compared with the 2 weeks before this period (0¼no effect
on constipation, 1¼mild relieving effect, 2¼moderate
relieving effect, 3¼ considerable relieving effect).
Statistics
The information obtained from the two baseline weeks was
combined, as was the information from the last 2 weeks of
the intervention periods, by calculating the mean of all
recorded values. The sum of symptoms (maximum 9 points)
was calculated by adding the daily average values of
abdominal pain, abdominal distension and flatulence (each
from 0 to 3 points).
The test yoghurt was compared with the control yoghurt
for defecation frequency, difficulty in defecation, hardness of
faeces and the sum of symptoms. The conventional
cross-over analysis (ANOVA) was performed to study the
treatment, period and carry-over effects. The comparison
of yoghurts, that is, treatment effect, is given as means
with 95% confidence intervals (CI95). Individual symptoms
(abdominal distension, pain and flatulence), and the
effectiveness scores of the yoghurts were analysed by using
the nonparametric Wilcoxon matched pairs test, and the
results are presented as medians. The McNemar test was used
for binary variables, and the marginal homogeneity test
(extension of the McNemar test) was used for variables with
more than two categories. Differences were considered
significant at Po0.05. The data were analysed using SPSS
(Version 13.0).
Results
Study compliance was good, and the intake of the study
yoghurts did not differ between the two intervention
periods. During the last 2 weeks of the test yoghurt period
30 subjects out of the 43 had eaten all the yoghurts given
them, and the mean intake of yoghurt was 13.5 per week
(range 11–14). During the control yoghurt period the mean
intake of yoghurts was 13.4 per week (range 8.5–15).
The intake of dietary fibre remained constant during the
intervention periods: on average 20.8 g during the test
yoghurt period and 22.3 g during the control yoghurt period
when dietary fibre from the yoghurt was not included. The
intake of drinks (1740 vs 1710ml) and amount of exercise
(P¼0.774) did not differ between the GOS and the control
yoghurt periods.
Defecation frequency was on average (mean7s.e.m)
5.770.5 times per week during the baseline period, and
significantly higher in the test yoghurt period than in the
control yoghurt period (8.070.6 vs. 7.170.5 times per week,
difference 0.9 CI95 0.2 to 1.6, P¼0.011, Figure 1a). Defeca-
tion was easier in the test yoghurt period than in the control
yoghurt period (1.3 vs 1.5 points, difference 0.2 CI95 0.3–
0.05, P¼0.010, Figure 1b). Stools were slightly softer in
the test yoghurt period compared with the control yoghurt
(2.1 vs 2.2 points, difference -0.1 CI95 0.2–0.004, P¼0.059,
Figure 1c). Period effects were not seen in any of the
variables. A carry-over effect was seen in the difficulty of
defecation, where the positive effect of test yoghurt was still
present during the following control yoghurt period
(P¼0.048).
Overall gastrointestinal symptoms did not differ between
the intervention periods (2.2 vs 2.2 points, difference 0.01
GOS relieve constipation
U Sairanen et al
1425
European Journal of Clinical Nutrition
CI95 0.4–0.5, P¼0.967, Figure 1d), but abdominal pain was
less severe in the test yoghurt period than in the control
yoghurt period (median scores 0.1 vs 0.3 points, P¼0.031,
Table 2). In five subjects, symptoms were reduced during the
test yoghurt period compared with the control yoghurt
period. In six subjects, the situation was the opposite, and
three of them suffered from all the individual symptoms
during the test yoghurt period.
The use of laxatives remained constant in the two
intervention periods. Eleven of the 43 subjects needed
laxatives during the intervention periods according to the
standardized schedule described above. Nine subjects used
laxatives during the control yoghurt period, and six during
the test yoghurt period. Thirteen subjects needed laxatives
during the baseline period.
Thirty-eight of the 43 subjects (88%) felt relief from the
test yoghurt and 31 (72%) from the control yoghurt
(P¼ 0.118). When the effectiveness was rated on a scale,
the test yoghurt relieved constipation more effectively than
the control yoghurt (median scores 2.0 vs 1.5 points,
P¼0.005).
Discussion
In the present study, a yoghurt containing a combination of
GOS, prunes and linseed was shown to be effective in the
treatment of mild constipation in the elderly. In severe
constipation, use of laxatives is needed. Our results show the
possibility and importance of self-treatment with nutritional
therapy in mild constipation. The effects of GOS, prunes and
linseed were not separated in the study. However, GOS were
considered to be the most effective component of the three,
and GOS contributed most of the fibre content of the
yoghurt. This combination was chosen because these food-
stuffs contain different effective substances: GOS are soluble
fibre, linseed contains fibre which is mostly insoluble but it
also contains a special soluble fibre known as mucilage, and
prunes contain fibre, sorbitol, xylitol and phenolic com-
pounds, which may affect the ability of prunes to enhance
gastrointestinal function.
The subjects in the present study were classified as
suffering from constipation as their bowels functioned less
than five times a week without laxatives or they complained
of difficulty in defecation. However, the bowel function of
many of the subjects was still fairly good. Therefore, the
result of this study can only be applied to subjects with mild
constipation.
As can be seen from both the subjective opinions of the
effectiveness of the yoghurts and the objective data, the
control yoghurt also seemed to be effective in relieving
constipation. L. acidophilus and the bifidobacteria used in
both yoghurts may have altered the colonic environment
and made defecation easier, even in the case of the control
yoghurt (Adolfsson et al., 2004). The aim of our study was
not to investigate the effects of different bacteria, and
therefore the same ferment was used in both the control
yoghurt and the test yoghurt.
Our finding of the alleviating effect of GOS, prunes and
linseed on constipation accords with earlier studies on GOS
(Shitara, 1988; Deguchi et al., 1997; Teuri and Korpela, 1998),
in which the amount of GOS consumed per day ranged from
9 to 18.5 g. Because the present yoghurt contained such a
small amount of prunes and linseed, the major effect was
most probably from the GOS. However, even small quan-
tities of prunes and linseed might have had a synergistic
effect with the GOS.
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Figure 1 Defecation frequency (times per week), difficulty in
defecation (from 0¼ easy to 3¼difficult), hardness of faeces (from
0¼ liquid to 3¼hard), and sum of symptoms per day (includes
flatulence, abdominal pain, and abdominal distension, all from
0¼no symptom to 3¼ severe symptoms) during the three study
periods (mean7s.e.m., n¼43).
Table 2 The average gastrointestinal symptom scores per day during the baseline period, the test yoghurt period and the control yoghurt period
(n¼43)
Symptoma Baseline median (range) GOS median (range) Control median (range) GOS vs. control P-valueb
Abdominal distension 0.4 (0–2.1) 0.3 (0–2.9) 0.6 (0–2.0) 0.473
Abdominal pain 0.2 (0–1.9) 0.1 (0–2.4) 0.3 (0–2.0) 0.031
Flatulence 1.2 (0–2.4) 1.1 (0–3.0) 1.0 (0–2.5) 0.673
Abbreviation: GOS, galacto-oligosaccharides.
aIntensity of each symptom from 0¼no symptom to 3¼ severe symptoms.
bWilcoxon matched pair test.
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The intake of fibre by the elderly subjects in this study
was on average low. If GOS are included in the fibre
component, it can be seen that the intake of fibre in the
GOS period was about one and a half times that of the
control period. The importance of fibre in alleviating
constipation is well known (Taylor, 1990). In addition,
GOS are reported to have a bifidogenic effect (Ito et al.,
1990; Bouhnik et al., 1997; Boehm et al., 2002; Moro et al.,
2002; Knol et al., 2005; Rinne et al., 2005), and here they may
have altered bowel function through an increase in bifido-
bacteria and a change in the colonic environment. However,
there were some subjects on whom the GOS had no effect; in
fact, their constipation even became more severe. The
etiology of constipation is complex and it was therefore
not surprising that the effects of GOS varied considerably
among the subjects (Livesey, 2001; Muller-Lissner et al.,
2005b).
We could not reduce the use of laxatives to any significant
extent by means of the test yoghurt. There were five subjects
who were able to omit laxatives during the test yoghurt
period, but there were also two who needed laxatives only
during that period. If a subject needs laxatives, which
stimulate the intestinal nerves, yoghurt with fibre may be
far too mild to reduce constipation. However, it may replace
some bulk laxatives whose mechanism of action is fairly
similar to that of GOS.
In most subjects, the adverse gastrointestinal symptoms
did not increase in the GOS yoghurt period, although
GOS are highly fermentable in the colon and in some
studies have been found to increase gastrointestinal symp-
toms (Ito et al., 1990; Teuri et al., 1998). Abdominal pain was
on the whole reduced in the present study. However, six of
the 43 subjects definitely experienced more gastrointestinal
symptoms in the GOS yoghurt period than in the control
yoghurt period. Indeed, gastrointestinal symptoms are
common side effects of indigestible carbohydrates, which
give rise to fermentation in the colon (Attar et al., 1999;
Suarez et al., 1999; Cummings et al., 2001). In our earlier
constipation study (Teuri and Korpela 1998), gastrointestinal
symptoms were not noticeably intensified in any of the
subjects ingesting the GOS yoghurt. The GOS dose was then
9 g and no prunes or linseed were included. Perhaps
increasing the amount of GOS to 12 g per day in the present
study exacerbated the symptoms in the most sensitive
subjects, and some subjects may not have tolerated prunes
or linseed.
In conclusion, yoghurt containing GOS, linseed and
prunes reduced the severity of mild constipation in the
elderly subjects without significant adverse effects, though
the use of laxatives could not be totally excluded.
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